Rivus Pharmaceuticals
Developing new oral medicines to advance cardiometabolic health
29 employees · est. 2019 · Charlottesville, United Stat...
Verdiva Bio
Transforming lives by accelerating innovation in cardiometabolic health
76 employees · est. 2025 · London, United Kingdom
Rivus Pharmaceuticals is the older company (2019 vs 2025); Verdiva Bio is the larger of the two.
2 signals in the last 90 days
Side-by-Side Comparison
| Metric | Rivus Pharmaceuticals | Verdiva Bio |
|---|---|---|
| Founded | ||
| Founded | 2019 older | 2025 |
| Headquarters | ||
| Headquarters | Charlottesville, United States | London, United Kingdom |
| Employees | ||
| Employees | 29 | 76 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series B | Series A |
| Total Funding | ||
| Total Funding | $167.00M | $411.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 1 |
| Services | ||
| Services | Not tracked yet | Development of oral and injectable peptide therapies, Clinical trials for obesity and cardiometabolic diseases, Research and development of cardiometabolic treatments, Engineering peptide formulations |
| Target Customers | ||
| Target Customers | Not tracked yet | Individuals with obesity, Healthcare providers, Patients with cardiometabolic diseases, Pharmaceutical companies and partners |
| Taxonomy | ||
| Taxonomy | Not tracked yet | Cardiometabolic Health, Obesity, Next-Generation Therapies, GLP-1 Peptide, Clinical Development, Phase 1 Study, Once-Weekly Dosing, Amylin Molecules, Oral Agonists, Subcutaneous Agonists, Gut-Brain Biology, Drug Development, Therapeutic Options, Healthier Weight Loss |
| Website | ||
| Website | rivuspharma.com | verdivabio.com |
About Rivus Pharmaceuticals
Rivus Pharmaceuticals, Inc., founded in 2019, is dedicated to transforming the treatment of cardio-metabolic disease with its innovative approach. The company focuses on advancing a new class of oral, once daily, small molecule therapeutics known as Controlled Metabolic Accelerators (CMAs). These CM...
About Verdiva Bio
Verdiva Bio, founded in 2025, is an emerging leader in the field of cardiometabolic health, with its headquarters in the United Kingdom. The company is committed to developing next-generation therapies aimed at transforming the lives of individuals suffering from obesity and related complications, f...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Rivus Pharmaceuticals and Verdiva Bio — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Rivus Pharmaceuticals and Verdiva Bio — by email.
Frequently Asked Questions
Compare Rivus Pharmaceuticals with someone else
Start typing a company name or domain.